Home
Live Updates
Alterity Therapeutics Presents New Data Demonstrating Potential of ATH434 to Treat Rare Neurodegenerative Disease Friedreichs Ataxia : comparemela.com
Alterity Therapeutics Presents New Data Demonstrating Potential of ATH434 to Treat Rare Neurodegenerative Disease Friedreich's Ataxia
– New Evidence Indicates ATH434 can Function as an Iron Chaperone to Redistribute Iron – MELBOURNE, Australia and SAN FRANCISCO, April 29, 2024 -- Alterity Therapeutics , a...
Related Keywords
Melbourne ,
Victoria ,
Australia ,
Boston ,
Massachusetts ,
United States ,
California ,
San Francisco ,
Remy Bernarda ,
Hannah Howlett ,
David Stamler ,
National Institute Of Neurological Disorders ,
National Institutes Of Health ,
Nasdaq ,
Alterity Therapeutics ,
European Commission ,
Securities Exchange ,
World Orphan Drug Congress United States ,
New Evidence Indicates ,
Iron Chaperone ,
Redistribute Iron ,
Unique Iron Targeting Drug ,
Treating Friedreich ,
Ashley Pall ,
Pharmaceutical Sciences ,
Wayne State ,
Chief Executive Officer ,
Multiple System ,
Multiple System Atrophy ,
National Institutes ,
National Institute ,
Neurological Disorders ,
Media Contacts ,
Securities Act ,
Securities Exchange Act ,
Annual Report ,
Markets ,
comparemela.com © 2020. All Rights Reserved.